Japan Study Links COVID mRNA Vaccines to 210,000 Excess Deaths

New York City is experiencing a late-summer surge in Covid-19 cases, with patients reporting symptoms and seeking vaccinations amid the emergence of the Stratus variant. Health Secretary Robert F. Kennedy Jr. announced new restrictions on Covid vaccine eligibility as the FDA rescinded emergency use authorizations for Pfizer and Moderna vaccines, sparking internal controversy within the CDC and resignations from top officials who warned these changes could erode trust and threaten lives. Meanwhile, a controversial study published on a pre-print platform claims that mRNA vaccines may cause toxic synergy with the virus, leading to increased chronic illness and mortality, though this viewpoint contrasts with the broader expert consensus on vaccine safety. Additionally, a major Japanese study revealed a significant rise in excess mortality following an intensive mRNA vaccine campaign, reporting over 210,000 unexplained deaths during 2022–2023, with only a fraction attributed directly to Covid infections. These findings have fueled global debate about the long-term safety of repeated mRNA vaccinations, especially given Japan's high per capita vaccine dose administration. At the same time, influenza vaccination campaigns are preparing to start in October to mitigate the impact of the upcoming flu season, which experts fear could be severe based on southern hemisphere data.